NCT07087054 - Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen | Biotech Hunter

Enrollment

141

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

August 31, 2027

Study Completion Date

January 31, 2030

Conditions

Carcinoid SyndromeCarcinoidCarcinoid TumorCarcinoid Tumor of IleumCarcinoid Tumor of CecumCarcinoid Tumor of LiverCarcinoid Tumor of PancreasCarcinoid Syndrome DiarrheaCarcinoid Intestine Tumor

Interventions

DRUG

Paltusotine

Experimental Drug: Randomized

DRUG

Placebo

Matching Placebo Drug: Randomized

Trial Locations (10)

2000

RECRUITING

Instituto Médico de la Fundación Estudios Clínicos, Santa Fe

22903

RECRUITING

University of Virginia Comprehensive Cancer Center, Charlottesville

30322

RECRUITING

Winshop Cancer Institute - Emory University, Atlanta

40536

RECRUITING

University of Kentucky Medical Center, Lexington

48202

RECRUITING

Henry Ford Cancer - Detroit, Detroit

70006

RECRUITING

Louisiana State University Health Sciences, Metairie

92663

RECRUITING

Hoag Memorial Hospital Presbyterian, Newport Beach

06510

RECRUITING

Yale University - New Haven Hospital - Yale Cancer Center, New Haven

C1180AAX

RECRUITING

Sanatorio Guemes, Buenos Aires

01509-010

RECRUITING

AC Camargo Cancer Center, São Paulo